Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Identifying Key Metrics and Analyzing Data on Performance Gaps Enhance MLR Review Processes

Data-driven analysis of key performance metrics can uncover hidden inefficiencies in MLR (medical, legal, and regulatory) review workflows for life sciences companies. By identifying and closing performance gaps, organizations can convert their compliance review processes from bottlenecks into competitive advantages. EY's approach emphasizes systematic measurement and continuous improvement within promotional material review.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

By Annalise Ludtke · Jessy HorrellMlr ReviewPromotional Material Review ProcessPromotional Review Data
Share

Key takeaways

01

Tracking the right KPIs in MLR review processes reveals workflow inefficiencies that are otherwise invisible to compliance teams.

02

Analyzing performance gaps enables life sciences companies to streamline promotional material approvals and reduce cycle times.

03

A data-driven MLR review strategy can reframe compliance from a cost center into a source of competitive differentiation.

Leveraging data to refine and enhance the promotional material review (MLR) process has become crucial in the ever-evolving landscape of life sciences. Organizations striving for efficiency and compliance need to understand how best to utilize available data to impact their workflow and overall success significantly.

Organizations striving for efficiency and compliance need to understand how best to utilize available data to impact their workflow and overall success significantly.

How can organizations use data to improve their MLR review processes? What specific metrics and insights should they focus on?

This episode of “Amend & Progress,” Vodori’s go-to podcast for all things promotional material features Jessy Horrell, VP of Customer Success at Vodori. She joins the host of the show, Annalise Ludtke to discuss the real-time analysis of promotional review data, uncovering insights and exploring how organizations can utilize this data to drive process improvements.

Key Points of Discussion

  • High-Level Metrics: Analyzing key performance indicators (KPIs) such as average job duration, feedback incorporation time, and review duration compared to industry benchmarks.
  • Workload Distribution: Understanding the distribution of tasks among reviewers and identifying potential bottlenecks or resource imbalances.
  • Performance Gaps: Identifying bottom performers and discussing strategies for supporting and improving their performance.

Jessy Horrell serves as the VP of Customer Success at Vodori, where she oversees customer onboarding and ongoing success with Vodori’s products. With a data-driven approach, Jessy helps clients understand and utilize their data to make informed decisions and enhance their MLR processes. Jessy holds a degree in Business Administration and has received numerous accolades for her contributions to customer success in the life sciences industry.

About the author

AL
Annalise Ludtke

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Gene therapies, early detection, and GLP-1 drugs are reshaping enterprise healthcare procurement

Recent advancements in healthcare, including gene therapies, early detection methods, and GLP-1 drugs, are influencing enterprise healthcare procurement strategies. These innovations are impacting benefit plan adjustments and procurement decision-making processes. The healthcare industry is experiencing a notable shift due to FDA-cleared treatments and predictive diagnostics.

  • 01Gene therapies and early detection methods are transforming healthcare procurement.
  • 02FDA-cleared treatments are prompting shifts in benefit plans.
  • 03Advancements are accelerating decision-making in healthcare procurement.

Jul 14, 2026

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

AL
Annalise Ludtke

Manager, Life Sciences Regulatory & Compliance at EY

Annalise Ludtke is a manager at EY specializing in life sciences regulatory and compliance. She focuses on optimizing medical, legal, and regulatory (MLR) review processes through data-driven methodologies. Her work helps pharmaceutical and biotech organizations transform compliance workflows into operational advantages.

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512